In psoriasis treatment, luteolin has shown strong anti-inflammatory properties in keratinocytes by inhibiting TNF-α-induced production of inflammatory mediators, including IL-6, IL-8, and VEGF. This evidence concerns the gene IL6 and psoriasis.